Besides, elevated HIF-1α expression correlates with poor prognosis and cytarabine resistance in NPM1-mutated/FLT3-ITD-negative AML subtypes, establishing it as a predictive biomarker (133). Here, NPM1 is linked to acute myeloid leukemia.